Biodegradable, multifunctional DNAzyme nanoflowers for enhanced cancer therapy
Source abstract
Abstract
Safety and efficiency remain the critical hurdles hindering the practical application of gene agents, even though great effort has been made to develop various gene carriers. Herein, we present a novel biodegradable cancer therapeutic system based on DNA nanoflowers (DNFs) for targeted dual gene silencing. The therapeutic system was constructed by copying a rolling circle amplification template to produce long single-stranded DNAs with cell targeting and dual gene-silencing capability. The structure of the DNFs collapsed at acidic pH due to the decomposition of the co-assembled magnesium pyrophosphate, generating Mg2+ ions that act as cofactors for the DNAzymes and increase their ability to recognize and cleave target mRNAs. In vitro and in vivo studies demonstrated that the multifunctional DNFs showed promise for targeted cancer cell recognition, gene silencing, induction of apoptosis and inhibition of tumor growth. Considering the enhanced therapeutic effect and biocompatibility of this therapeutic platform, it is anticipated to be of great interest for the clinical treatment of cancers. Embedding multiple gene-silencing agents within the petal-like surfaces of a DNA nanostructure makes it easier to target tumors in live mice. Controlled laboratory studies have shown that RNA-cleaving DNAzymes can stifle the expression of genes that contribute to cancer production, but their activity in complex biological systems is debated. Jinchao Zhang from Hebei University in China and co-workers have developed a more efficient anti-tumor agent by combining two DNAzymes with a single-stranded aptamer that has an affinity for cancer cells. Using rolling circle amplification, the researchers self-assembled these components, along with magnesium pyrophosphate, into crinkled ’nanoflower‘ spheres. Both in vitro and in vivo trials revealed the material catalytically inhibited two RNAs simultaneously, boosting efficiency compared to single DNAzymes. Acidic digestion of the nanoflowers also released magnesium ions that acted as co-factors for gene silencing. We present a novel biodegradable cancer therapeutic system based on DNAzyme nanoflowers for targeted dual gene silencing. The therapeutic system was constructed by copying rolling circle amplification template to produce long single-stranded DNAs with cell targeting and dual gene silencing capability. The structure of the nanoflowers collapsed at acidic pH due to decomposition of the co-assembled magnesium pyrophosphate, generating Mg2+ ions which act as cofactors for the DNAzymes and increase their ability to recognize and cleave target mRNAs. Considering its enhanced therapeutic effect and biocompatibility, this platform is expected to be of great interest for clinical treatment of cancers.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Alvarez, R. D., Barnes, M. N., Gomez-Navarro, J., Wang, M., Strong, T. V., Arafat, W., Arani, R. B., Johnson, M. R., Roberts, B. L., Siegal, G. P. & Curiel, D. T. A cancer gene therapy approach utilizing an anti-ErbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin. Cancer Res. 6, 3081–3087 (2000).
2. Schiffelers, R. M., Ansari, A., Xu, J., Zhou, Q., Tang, G., Storm, G., Lu, P. Y., Scaria, P. V. & Woodle, C. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149(2004).10.1093/nar/gnh140 ↗
3. Devi, G. R. siRNA-based approaches in cancer therapy. Cancer Gene Ther. 13, 819–829 (2006).10.1038/sj.cgt.7700931 ↗
4. Scherer, L. J. & Rossi, J. J. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21, 1457–1465 (2003).10.1038/nbt915 ↗
5. Zhao, Y., Duan, S., Yu, B., Liu, F., Cheng, G. & Xu, F. J. Gd(III) ion-chelated supramolecular assemblies composed of PGMA-based polycations for effective biomedical applications. NPG Asia Mat. 7, e197 (2015).10.1038/am.2015.67 ↗
6. Li, R. Q., Wu, Y., Zhi, Y., Yang, X., Li, Y., Xu, F. J. & Du, J. PGMA-based star-like polycations with plentiful hydroxyl groups act as highly efficient miRNA delivery nanovectors for effective applications in heart diseases. Adv. Mater. 28, 7204–7212 (2016).10.1002/adma.201602319 ↗
7. Silverman, S. K. In vitro selection, characterization, and application of deoxyribozymes that cleave RNA. Nucleic Acids Res. 33, 6151–6163 (2005).10.1093/nar/gki930 ↗
8. Dass, C. R. Deoxyribozymes: cleaving a path to clinical trials. Trends Pharmacol. Sci. 25, 395–397 (2004).10.1016/j.tips.2004.06.001 ↗
9. Dass, C. R., Khachigian, L. M., Choong, P. F., Dass, C. R., Khachigian, L. M. & Choong, P. F. c-Jun knockdown sensitizes osteosarcoma to doxorubicin. Mol. Cancer Ther. 7, 243–251 (2008).10.1158/1535-7163.MCT-07-0510 ↗
10. Marquardt, K., Eicher, A. C., Dobler, D., Mäder, U., Schmidts, T., Renz, H. & Runkel, F. Development of a protective dermal drug delivery system for therapeutic DNAzymes. Int. J. Pharm. 479, 150–158 (2015).10.1016/j.ijpharm.2014.12.043 ↗
11. Tack, F.,, Noppe, M., Van, D. A., Dekeyzer, N., Van Der Leede, B. J.,, Bakker, A., Wouters, W., Janicot, M. & Brewster, M. E. Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach. Pharmazie 63, 221–225 (2008).
12. Ryoo, S. R., Jang, H., Kim, K. S., Lee, B., Kim, K. B., Kim, Y. K., Yeo, W. S., Lee, Y., Kim, D. E. & Min, D. H. Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown. Biomaterials 33, 2754–2761 (2012).10.1016/j.biomaterials.2011.12.015 ↗
13. Kim, S., Ryoo, S. R., Na, H. K., Kim, Y. K., Choi, B. S., Lee, Y., Kim, D. E. & Min, D. H. Deoxyribozyme-loaded nano-graphene oxide for simultaneous sensing and silencing of the hepatitis C virus gene in liver cells. Chem. Commun. 49, 8241–8243 (2013).10.1039/c3cc43368d ↗
14. Fan, H., Zhao, Z., Yan, G., Zhang, X., Yang, C., Meng, H., Chen, Z., Liu, H. & Tan, W. A smart DNAzyme-MnO2 nanosystem for efficient gene silencing. Angew. Chem. Int. Ed. 54, 4801–4805 (2015).10.1002/anie.201411417 ↗
15. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next, generation. Cell 144, 646–674 (2011).10.1016/j.cell.2011.02.013 ↗
16. Hao, X., Hu, X., Zhang, C., Chen, S., Li, Z., Yang, X., Liu, H., Jia, G., Liu, D., Ge, K., Liang, X. J. & Zhang, J. Hybrid mesoporous silica-based drug carrier nanostructures with improved degradability by hydroxyapatite. ACS Nano 9, 9614–9625 (2015).10.1021/nn507485j ↗
17. Wang, Z. G. & Ding, B. DNA-based self-assembly for functional nanomaterials. Adv. Mater. 25, 3905–3914 (2013).10.1002/adma.201301450 ↗
18. Sun, W., Jiang, T., Lu, Y., Reiff, M., Mo, R., Gu, Z. & Cocoon-Like Self-Degradable DNA Nanoclew for anticancer drug delivery. J. Am. Chem. Soc. 136, 14722–14725 (2014).10.1021/ja5088024 ↗
19. Zhu, G., Hu, R., Zhao, Z., Chen, Z., Zhang, X. & Tan, W. Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications. J. Am. Chem. Soc. 135, 16438–16445 (2013).10.1021/ja406115e ↗
20. Lee, J. B., Hong, J., Bonner, D. K., Poon, Z. & Hammond, P. T. Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat. Mater. 11, 316–322 (2012).10.1038/nmat3253 ↗
21. Lee, H., Lytton-Jean, A. K., Chen, Y., Sehgal, A., Querbes, W., Zurenko, C. S., Jayaraman, M., Peng, C. G., Charisse, K., Borodovsky, A., Manoharan, M., Donahoe, J. S., Truelove, J., Nahrendorf, M., Langer, R. & Anderson, D. G. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7, 389–393 (2012).10.1038/nnano.2012.73 ↗
22. Li, J., Zheng, C., Cansiz, S., Wu, C. C., Xu, J. H., Cui, C., Liu, Y., Hou, W., Wang, Y., Zhang, L., Teng, I.-T., Yang, H. & Tan, W. Self-assembly of DNA nanohydrogels with controllable size and stimuli-responsive property for targeted gene regulation therapy. J. Am. Chem. Soc. 137, 1412–1415 (2015).10.1021/ja512293f ↗
23. Liao, W. C., Sohn, Y. S., Riutin, M., Cecconello, A., Parak, W., Nechushtai, R. & Willner, I. The application of stimuli-responsive VEGF- and ATP-aptamer-based microcapsules for the controlled release of an anticancer drug, and the selective targeted cytotoxicity toward cancer cells. Adv. Funct. Mater. 26, 4262–4273 (2016).10.1002/adfm.201600069 ↗
24. Yang, X., Liu, X., Liu, Z., Pu, F., Ren, J. & Qu, X. Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv. Mater. 24, 2890–2895 (2012).10.1002/adma.201104797 ↗
25. Reyes-Reyes, E. M., Šalipur, F. R., Shams, M., Forsthoefel, M. K. & Bates, P. J. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation. Mol. Oncol 9, 1392–1405 (2015).10.1016/j.molonc.2015.03.012 ↗
26. Ali, M. M., Li, F., Zhang, Z., Zhang, K., Kang, D. K., Ankrum, J. A., Le, X. C. & Zhao, W. Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine. Chem. Soc. Rev. 43, 3324–3341 (2014).10.1039/c3cs60439j ↗
27. Hu, R., Zhang, X., Zhao, Z., Zhu, G., Chen, T., Fu, T. & Tan, W. DNA Nanoflowers for multiplexed cellular imaging and traceable targeted drug delivery. Angew. Chem. Int. Ed. 53, 5821–5826 (2014).10.1002/anie.201400323 ↗
28. Wang, F., Lu, C. H., Liu, X., Freage, L. & Willner, I. Amplified and multiplexed detection of DNA using the dendritic rolling circle amplified synthesis of DNAzyme reporter units. Anal. Chem. 86, 1614–1621 (2014).10.1021/ac4033033 ↗
29. Zhang, M., Sun, Y. F. & Luo, S. Ani-Survivin DNAzymes inhibit cell proliferation and migration in breast cancer cell line MCF-7. Asian Pac. J. Cancer Prev 13, 6233–6237 (2012).10.7314/APJCP.2012.13.12.6233 ↗
30. Shopsowitz, K. E., Roh, Y. H., Deng, Z. J., Morton, S. W. & Hammond, P. T. RNAi-microsponges form through self-assembly of the organic and inorganic products of transcription. Small 10, 1623–1633 (2014).10.1002/smll.201302676 ↗
31. Bloch-Frankenthal, L. The role of magnesium in the hydrolysis of sodium pyrophosphate by inorganic pyrophosphatase. Biochem. J. 57, 87–92 (1954).10.1042/bj0570087 ↗
32. Fu, S. & Sun, L. Q. DNAzyme-based therapeutics for cancer treatment. Future Med. Chem. 7, 1701–1707 (2015).10.4155/fmc.15.106 ↗
33. Shieh, Y. A., Yang, S. J., Wei, M. F. & Shieh, M. J. Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 4, 1433–1442 (2015).10.1021/nn901374b ↗
34. Zhang, S., Li, J., Lykotrafitis, G., Bao, G. & Suresh, S. Size-dependent endocytosis of nanoparticles. Adv. Mater. 21, 419–424 (2009).10.1002/adma.200801393 ↗
35. Nazarenus, M., Zhang, Q., Soliman, M. G., Del, Pino, P., Pelaz, B., Carregal-Romero, S., Rejman, J., Rothen-Rutishauser, B., Clift, M. J., Zellner, R., Nienhaus, G. U., Delehanty, J. B., Medintz, I. L. & Parak, W. J. In vitro interaction of colloidal nanoparticles with mammalian cells: what have we learned thus far? Beilstein J. Nanotechnol. 5, 1477–1490 (2014).10.3762/bjnano.5.161 ↗
36. Fadok, V. A., Bratton, D. L., Frasch, S. C., Warner, M. L. & Henson, P. M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5, 551–562 (1998).10.1038/sj.cdd.4400404 ↗